EGFR-TKI, Cardiac adverse events, Cardiotoxicity, Targeted therapies, Pharmacovigilance analysis
Epidermal growth factor receptor-tyrosine kinase inhibitors, Anti-vascular endothelial growth factor (VEGF) antibodies, Smoking, lung cancer, Meta-analysis.